Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Serum Vitamin D Concentrations in CoVID19 Patients
Azadeh et al., J. Mazandaran Univ. Med. Sci. 31:195
Azadeh et al., Serum Vitamin D Concentrations in CoVID19 Patients, J. Mazandaran Univ. Med. Sci. 31:195
Apr 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 80 COVID-19 patients in Iran and 70 healthy controls, showing significantly lower vitamin D levels in COVID-19 patients.
Azadeh et al., 30 Apr 2021, Iran, peer-reviewed, 6 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: Serum Vitamin D Concentrations in CoVID19 Patients 1 Hossein Azadeh , 2 Akbar Hedayatizadeh-Omran , 3 Majid Saeedi , 4 Laleh Vahedi-Larijani , 5 Hossein Mehravaran , 6 Keyvan Heydari 1 Assistant Professor, Department of Internal Medicine, Rheumatology Division, Mazandaran University of Medical Sciences, Sari, Iran Associate Professor, Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran 3 Professor, Department of Pharmaceutics, Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran 4 Associate Professor, Department of Pathology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran 5 Assistant Professor, Department of Internal Medicine, Pulmonary and Critical Care Division, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran 6 Medical Student, Student Research Committee, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran 2 (Received November 8, 2020 ; Accepted March 7, 2021) Abstract Background and purpose: Vitamin D deficiency is highly prevalent in Iran. Death toll due to the Coronavirus Disease 2019 (COVID-19) is high in this country. The purpose of the present investigation was to provide more information on the relationship between serum levels of vitamin D in confirmed cases of COVID-19 in north of Iran. Materials and methods: This cross-sectional descriptive study was performed in COVID-19 patients (n=80) attending Sari Imam Khomeini Hospital, Iran 2020, who were confirmed for COVID-19 infection with CT-Scan or RT-PCR. Seventy healthy individuals were also examined as the control group. SPSS V19 was applied for data analysis. Results: In this study, 80 patients with COVID-19 (mean age: 57.22 ± 17.44 years old) and 70 healthy individuals (mean age: 48.69 ± 12.99 years) were studied. There were 38 and 35 males in these two groups, respectively. Serum Vitamin D levels were significantly lower in patients with COVID-19 than those in the control group (18.72 ± 12.53 vs. 30.86 ± 15.19 ng/ml, P< 0.001). Conclusion: This study showed that serum levels of Vitamin D were lower in patients with COVID-19 than healthy individuals and frequency of Vitamin D deficiency was higher in these patients. Hence, further studies are needed to clarify the role of serum Vitamin D concentrations in patients with COVID-19 infection. Keywords: Vitamin D, COVID-19, SARS CoV-2, cholecalciferol J Mazandaran Univ Med Sci 2021; 31 (195): 30-36 (Persian). * Corresponding Author: Keyvan Heydari - Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran (E-mail: K1heydari96@Gmail.com) 30 ‫ﭘﮋوﻫﺸﻲ‬ ‫ﻣﺠــﻠــــﻪ داﻧـﺸــــﮕﺎه ﻋــﻠــــﻮم ﭘــﺰﺷــﻜـــــﻲ ﻣــﺎزﻧــــﺪران‬ ‫دوره ﺳﻲ و ﻳﻜﻢ ﺷﻤﺎره ‪ 195‬ﻓﺮوردﻳﻦ ﺳﺎل ‪(30-36) 1400‬‬ ‫ﺳﻄﺢ ﺳﺮﻣﻲ وﻳﺘﺎﻣﻴﻦ ‪ D‬در ﺑﻴﻤﺎران ﻣﺒﺘﻼ ﺑﻪ ‪CoVID-19‬‬ ‫ﺣﺴﻴﻦ آزاده‬ ‫‪1‬‬ ‫اﻛﺒﺮ ﻫﺪاﻳﺘﻲ زاده ﻋﻤﺮان‬ ‫ﻣﺠﻴﺪ ﺳﻌﻴﺪي‬ ‫‪2‬‬ ‫‪3‬‬ ‫ﻻﻟﻪ واﺣﺪي ﻻرﻳﺠﺎﻧﻲ‬ ‫ﺣﺴﻴﻦ ﻣﻬﺮآوران‬ ‫ﻛﻴﻮان ﺣﻴﺪري‬ ‫‪4‬‬ ‫‪5‬‬ ‫‪6‬‬ ‫ﭼﻜﻴﺪه‬ ‫ﺳﺎﺑﻘﻪ و ﻫﺪف‪ :‬ﺑﺎ ﺗﻮﺟﻪ ﺑﻪ ﺷﻴﻮع ﺑﺎﻻي ﻛﻤﺒﻮد وﻳﺘﺎﻣﻴﻦ ‪ D‬در ﻛﺸﻮر اﻳﺮان و ﻫﻤﭽﻨﻴﻦ ﻣﻴﺰان ﺑﺎﻻي ﻣﺮگ و ﻣﻴـﺮ ﻣـﺮﺗﺒﻂ ﺑـﺎ‬ ‫ﻛﻮوﻳﺪ در ﺷﻤﺎل اﻳﺮان‪ ،‬ﺑﺮرﺳﻲ ﺳﻄﺢ ﺳﺮﻣﻲ وﻳﺘﺎﻣﻴﻦ ‪ D‬در ﺑﻴﻤﺎران ﻣﺒـﺘﻼ ﺑـﻪ ﻛﻮوﻳـﺪ ‪ 19‬و ﻣﻘﺎﻳـﺴﻪ آن ﺑـﺎ اﻓـﺮاد ﺳـﺎﻟﻢ در اﻳـﻦ‬ ‫ﻣﻄﺎﻟﻌﻪ اﻧﺠﺎم ﺷﺪ‪.‬‬ ‫ﻣﻮاد و روشﻫﺎ‪ :‬اﻳﻦ ﻣﻄﺎﻟﻌﻪ ﺗﻮﺻﻴﻔﻲ‪ -‬ﻣﻘﻄﻌﻲ در ﺳﺎل ‪ 1399‬و ﺑﺮ روي ‪ 80‬ﺑﻴﻤﺎر ﻣﺒﺘﻼ ﺑﻪ ﻛﻮوﻳـﺪ ‪ 19‬ﻣﺮاﺟﻌـﻪﻛﻨﻨـﺪه ﺑـﻪ‬ ‫ﺑﻴﻤﺎرﺳﺘﺎن اﻣﺎم ﺧﻤﻴﻨﻲ)ره( ﺳﺎري‪ ،‬ﻛﻪ ﺑﻴﻤﺎري اﻳﺸﺎن ﺗﻮﺳﻂ ‪..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit